期刊
CANCER RESEARCH
卷 78, 期 10, 页码 2747-2759出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-17-1900
关键词
-
类别
资金
- NCI [P30 CA42014]
- V Foundation [V2015-003]
- Weill-Cornell Program in Mendelian Genetics
- Utah Genome Project
- Huntsman Cancer Institute
- Utah Population Database (UPDB)
- Utah Cancer Registry (UCR)
- Icahn School of Medicine at Mount Sinai Office of Research Infrastructure of the NIH [S10OD018522]
- [R01 CA167824]
- [R01 CA13464]
- [R01 CA178765]
- [T15 LM007124]
- [R21 CA152336]
- [LLS 6067-09]
- [HHSN261201000026C]
- NATIONAL CANCER INSTITUTE [P30CA042014, R21CA152336, R01CA178765, R01CA134674, P30CA008748, R01CA167824, P30CA021765] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104424] Funding Source: NIH RePORTER
- NATIONAL LIBRARY OF MEDICINE [T15LM007124] Funding Source: NIH RePORTER
- OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER
Given the frequent and largely incurable occurrence of multiple myeloma, identification of germline genetic mutations that predispose cells to multiple myeloma may provide insight into disease etiology and the developmental mechanisms of its cell of origin, the plasma cell (PC). Here, we identified familial and early-onset multiple myeloma kindreds with truncating mutations in lysine-specific demethylase 1 (1,SDI/KDM1A), an epigenetic transcriptional repressor that primarily demethylates histone H3 on lysine 4 and regulates hematopoietic stem cell self-renewal. In addition, we found higher rates of germline truncating and predicted deleterious missense KDM1A mutations in patients with multiple myeloma unselected for family history compared with controls. Both monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma cells have significantly lower KDM1A transcript levels compared with normal PCs. Transcriptome analysis of multiple myeloma cells from KDM1A mutation carriers shows enrichment of pathways and MYC target genes previously associated with myeloma pathogenesis. In mice, antigen challenge followed by pharmacologic inhibition of KDM1A promoted PC expansion, enhanced secondary immune response, elicited appearance of serum paraprotein, and mediated upregulation of MYC transcriptional targets. These changes are consistent with the development of MGUS. Collectively, our findings show that KDM1A is the first autosomal-dominant multiple myeloma germline predisposition gene providing new insights into its mechanistic roles as a tumor suppressor during post-germinal center B-cell differentiation. Significance: KDM1A is the first germline autosomal dominant predisposition gene identified in multiple myeloma and provides new insights into multiple myeloma etiology and the mechanistic role of KDM1A as a tumor suppressor during post-germinal center B cell differentiation. (C) 2018 AACR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据